West Historical Income Statement

WST Stock  USD 395.71  1.61  0.41%   
Historical analysis of West Pharmaceutical income statement accounts such as Depreciation And Amortization of 144.2 M, Total Revenue of 3.1 B, Gross Profit of 1.2 B or Other Operating Expenses of 2.4 B can show how well West Pharmaceutical Services performed in making a profits. Evaluating West Pharmaceutical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of West Pharmaceutical's future profits or losses.
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining West Pharmaceutical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether West Pharmaceutical is a good buy for the upcoming year.
  
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in West Pharmaceutical Services. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

About West Income Statement Analysis

West Pharmaceutical Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to West Pharmaceutical shareholders. The income statement also shows West investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

West Pharmaceutical Income Statement Chart

West Pharmaceutical Services Income Statement is one of the three primary financial statements used for reporting West's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of West Pharmaceutical revenue and expense. West Pharmaceutical Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, West Pharmaceutical's Total Operating Expenses is comparatively stable compared to the past year. Income Before Tax is likely to gain to about 732.9 M in 2024, whereas Selling General Administrative is likely to drop slightly above 194.7 M in 2024.

Total Revenue

Total revenue comprises all receipts West Pharmaceutical generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of West Pharmaceutical Services minus its cost of goods sold. It is profit before West Pharmaceutical operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of West Pharmaceutical. It is also known as West Pharmaceutical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Operating Income

Operating Income is the amount of profit realized from West Pharmaceutical operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of West Pharmaceutical Services is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.
Most accounts from West Pharmaceutical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into West Pharmaceutical current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in West Pharmaceutical Services. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
At this time, West Pharmaceutical's Total Operating Expenses is comparatively stable compared to the past year. Income Before Tax is likely to gain to about 732.9 M in 2024, whereas Selling General Administrative is likely to drop slightly above 194.7 M in 2024.
 2021 2022 2023 2024 (projected)
Total Revenue2.8B2.9B2.9B3.1B
Depreciation And Amortization126.1M120.6M137.3M144.2M

West Pharmaceutical income statement Correlations

0.950.90.980.830.820.850.970.990.83-0.330.820.860.030.790.910.8-0.350.740.240.590.75
0.950.990.990.960.950.970.990.970.96-0.380.950.95-0.110.770.960.94-0.470.860.290.650.89
0.90.990.970.990.980.990.970.940.99-0.380.980.95-0.170.750.950.97-0.470.890.30.640.92
0.980.990.970.920.910.931.00.990.92-0.370.910.92-0.050.790.950.89-0.440.820.270.630.84
0.830.960.990.920.990.990.930.881.0-0.331.00.95-0.240.710.930.99-0.480.910.290.620.93
0.820.950.980.910.991.00.920.860.99-0.360.990.96-0.270.670.940.99-0.510.910.350.670.94
0.850.970.990.930.991.00.940.890.99-0.360.990.97-0.240.690.950.99-0.50.910.340.670.93
0.970.990.971.00.930.920.940.980.93-0.370.920.93-0.060.780.960.9-0.460.830.280.650.85
0.990.970.940.990.880.860.890.980.88-0.340.870.880.020.820.920.85-0.350.780.220.560.78
0.830.960.990.921.00.990.990.930.88-0.311.00.95-0.270.690.941.0-0.480.910.330.660.95
-0.33-0.38-0.38-0.37-0.33-0.36-0.36-0.37-0.34-0.31-0.31-0.31-0.12-0.27-0.37-0.310.56-0.3-0.18-0.3-0.31
0.820.950.980.911.00.990.990.920.871.0-0.310.94-0.260.690.921.0-0.460.90.330.640.95
0.860.950.950.920.950.960.970.930.880.95-0.310.94-0.260.660.950.93-0.530.930.30.690.88
0.03-0.11-0.17-0.05-0.24-0.27-0.24-0.060.02-0.27-0.12-0.26-0.260.06-0.13-0.29-0.03-0.370.18-0.14-0.25
0.790.770.750.790.710.670.690.780.820.69-0.270.690.660.060.640.65-0.070.73-0.140.170.62
0.910.960.950.950.930.940.950.960.920.94-0.370.920.95-0.130.640.92-0.620.830.480.810.91
0.80.940.970.890.990.990.990.90.851.0-0.311.00.93-0.290.650.92-0.480.890.360.670.96
-0.35-0.47-0.47-0.44-0.48-0.51-0.5-0.46-0.35-0.480.56-0.46-0.53-0.03-0.07-0.62-0.48-0.43-0.64-0.79-0.59
0.740.860.890.820.910.910.910.830.780.91-0.30.90.93-0.370.730.830.89-0.430.120.550.87
0.240.290.30.270.290.350.340.280.220.33-0.180.330.30.18-0.140.480.36-0.640.120.810.5
0.590.650.640.630.620.670.670.650.560.66-0.30.640.69-0.140.170.810.67-0.790.550.810.78
0.750.890.920.840.930.940.930.850.780.95-0.310.950.88-0.250.620.910.96-0.590.870.50.78
Click cells to compare fundamentals

West Pharmaceutical Account Relationship Matchups

West Pharmaceutical income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization103.3M110.3M126.1M120.6M137.3M144.2M
Total Revenue1.8B2.1B2.8B2.9B2.9B3.1B
Gross Profit605.7M767.8M1.2B1.1B1.1B1.2B
Other Operating Expenses1.5B1.7B2.1B2.2B2.2B2.4B
Operating Income296.6M406.9M752.3M734M676M709.8M
Ebit296.6M406.9M752.3M734M738.4M775.3M
Ebitda399.9M517.2M878.4M854.6M875.7M919.5M
Cost Of Revenue1.2B1.4B1.7B1.8B1.8B1.9B
Total Operating Expenses311.6M360.9M423.5M402.2M421.8M442.9M
Income Before Tax291.8M401.3M748.9M679.9M698M732.9M
Total Other Income Expense Net(4.8M)(5.6M)(3.4M)(54.1M)(28.4M)(27.0M)
Net Income241.7M346.2M661.8M585.9M593.4M623.1M
Income Tax Expense59M72.5M107.2M114.7M122.3M128.4M
Interest Expense4.7M6.8M7.2M7.9M9M6.5M
Selling General Administrative272.7M302M362.8M343.7M353.4M194.7M
Research Development38.9M46.9M52.8M58.5M68.4M71.8M
Net Income Applicable To Common Shares232.8M346.2M661.8M585.9M673.8M707.5M
Net Income From Continuing Ops232.8M328.8M641.7M565.2M593.4M623.1M
Non Operating Income Net Other12.6M20M24.9M(25.5M)(29.3M)(27.9M)
Tax Provision59M72.5M107.2M114.7M122.3M83.0M
Interest Income3.8M6.8M7.2M2.8M28M29.4M
Extraordinary Items(81.9M)2.5M1.4M5.7M6.6M6.9M
Net Interest Income(4.7M)(6.8M)(7.2M)(2.8M)19M20.0M
Reconciled Depreciation103.4M109.1M122.3M120.6M137.3M124.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether West Pharmaceutical is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if West Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about West Pharmaceutical Services Stock. Highlighted below are key reports to facilitate an investment decision about West Pharmaceutical Services Stock:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in West Pharmaceutical Services. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Complementary Tools for West Stock analysis

When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Money Managers
Screen money managers from public funds and ETFs managed around the world
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Is West Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of West Pharmaceutical. If investors know West will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about West Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.334
Dividend Share
0.77
Earnings Share
7.88
Revenue Per Share
39.701
Quarterly Revenue Growth
0.033
The market value of West Pharmaceutical is measured differently than its book value, which is the value of West that is recorded on the company's balance sheet. Investors also form their own opinion of West Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is West Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because West Pharmaceutical's market value can be influenced by many factors that don't directly affect West Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between West Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if West Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, West Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.